The wrinkles soothing effect on the middle and lower face by intradermal injection of botulinum toxin type A

International Journal of Dermatology

Volumn 47, Issue 12, 2008, Pages 1287-1294

  Chang, Shao Ping ^a,b,c,d,e   Tsai, Hsiou Hsin ^a,b,c,d,e   Chen, Wei Yu ^a,b,c,d,e   Lee, Woan Ruoh ^a,b,c,d,e   Chen, Ping Ling ^a,b,c,d,e   Tsai, Tsung Hsien ^a,b,c,d,e  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; EOSIN; HEMATOXYLIN; PROCOLLAGEN; PROCOLLAGEN TYPE 1; UNCLASSIFIED DRUG;

ABNORMAL SENSATION; ADULT; APPLICATION SITE PAIN; APPLICATION SITE REACTION; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COLLAGEN SYNTHESIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG RESPONSE; ESTHETICS; FACIAL NERVE PARALYSIS; FEMALE; HISTOLOGY; HUMAN; HUMAN EXPERIMENT; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE WEAKNESS; PARALYSIS; PATIENT SATISFACTION; PERIORBITAL MUSCLE WEAKNESS; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; RHYTIDOPLASTY; SKIN BIOPSY; STINGING SENSATION; TREATMENT DURATION; TREATMENT OUTCOME; WRINKLE;

ADULT; BOTULINUM TOXIN TYPE A; COSMETIC TECHNIQUES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, INTRADERMAL; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; SKIN; SKIN AGING;

EID: 57049090642     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.03895.x     Document Type: Article

References (21)

1. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. J Pediatr Ophthalmol Strabismus 1980; 17: 21-25.
2. Schmid DM, Sauermann P, Werner M, et al. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol 2006; 176: 177-185.
3. Park MY, Ahn KY, Jung DS. Botulinum toxin type A treatment for contouring of the lower face. Dermatol Surg 2003; 29: 477-483.
4. Said S, Meshkinpour A, Carruthers A, et al. Botulinum toxin A: Its expanding role in dermatology and esthetics. Am J Clin Dermatol 2003; 4: 609-616.
5. Lee HJ, Lee DW, Park YH, et al. Botulinum toxin A for aesthetic contouring of enlarged medial gastrocnemius muscle. Dermatol Surg 2004; 30: 867-871.
6. Qerama E, Fuglsang-Frederiksen A, Kasch H, et al. A double-blind, controlled study of botulinum toxin A in chronic myofascial pain. Neurology 2006; 67: 241-245.
7. Piovesan EJ, Teive HG, Kowacs PA, et al. An open study of botulinum-A toxin treatment of trigeminal neuralgia. Neurology 2005; 65: 1306-1308.
8. Heckmann M, Ceballos-Baumann AO, Plewig G, et al. Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med 2001; 344: 488-493.
9. Naumann MK, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: Radomised parallel group, double blind,placebo controlled trial. BMJ 2001; 323: 596-599.
10. Yuraitis M, Jacob CI. Botulinum toxin for the treatment of facial flushing. Dermatol Surg 2004; 30: 102-104.
11. Sycha T, Graninger M, Auff E, et al. Botulinum toxin in the treatment of Raynaud's phenomenon: A pilot study. Eur J Clin Invest 2004; 34: 312-313.
12. Tamura BM, Lourenco LM, Platt A, et al. Cutis laxa: Improvement of facial aesthetics by using botulinum toxin. Dermatol Surg 2004; 30: 1518-1520.
13. Kurzen H, Schallreuter KU. Novel aspects in cutaneous biology of acetylcholine synthesis and acetylcholine receptors. Exp Dermatol 2004; 13: 27-3014.
14. Rzany B, Ascher B, Fratila A, et al. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region. Arch Dermatol 2006; 142: 320-326.
15. Trelles MA, Allones I, Luna R. Facial rejuvenation with a nonablative 1320 Am Nd: YAG laser: a preliminary clinical and histologic evaluation. Dermatol Surg 2001; 27: 111-116.
16. Zelickson BD, Kist D, Bernstein E, et al. Histological and ultrastructural evaluation of the effects of a radiofrequency-based nonablative dermal remodeling device: A pilot study. Arch Dermatol 2004; 140: 204-209.
17. Carruthers A, Carruthers J. Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids. Dermatol Surg 2005; 31: 1297-1303.
18. Matarasso A, Matarasso SL, Brandt FS, et al. Botulinum A exotoxin for the management of platysma bands. Plast Reconstr Surg 1999; 103: 645-652.
19. Karimipour DJ, Kang S, Johnson TM, et al. Microdermabrasion: A molecular analysis following a single treatment. J Am Acad Dermatol 2005; 52: 215-223.
20. Wang F, Garza LA, Kang S, et al. In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin. Arch Dermatol 2007; 143: 155-163.
21. Lee SK. Antibody-induced failure of botulinum toxin type A therapy in a patient with masseteric hypertrophy. Dermatol Surg 2007; 33: S105-S110.